Epilepsy Clinical Trials in Palo Alto, California
11 recruitingPalo Alto, California
Showing 1–11 of 11 trials
Recruiting
Phase 2Phase 3
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
Focal Epilepsy
Biohaven Therapeutics Ltd.390 enrolled124 locationsNCT06132893
Recruiting
Phase 1
Understanding Ketamine's Dissociative Effects (KD Study)
Epilepsy
Stanford University20 enrolled1 locationNCT04861051
Recruiting
Phase 2Phase 3
Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
Focal Epilepsy
Biohaven Therapeutics Ltd.390 enrolled174 locationsNCT06309966
Recruiting
Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
EpilepsyEpilepsy (Treatment Refractory)
Epiminder America, Inc.210 enrolled9 locationsNCT07110454
Recruiting
Not Applicable
Diagnosing Epilepsy To EffeCT Change
EpilepsyEpilepsy (Treatment Refractory)
Epiminder America, Inc.210 enrolled12 locationsNCT07110337
Recruiting
Phase 1Phase 2
A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy
EpilepsyDrug Resistant EpilepsySeizures, Focal
NaviFUS Corporation8 enrolled3 locationsNCT06388707
Recruiting
Phase 1Phase 2
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
Mesial Temporal Lobe Epilepsy
UniQure Biopharma B.V.12 enrolled18 locationsNCT06063850
Recruiting
Phase 3
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
Mesial Temporal Lobe Epilepsy
Neurona Therapeutics88 enrolled33 locationsNCT05135091
Recruiting
Phase 2
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
EpilepsyTuberous Sclerosis Complex
Darcy Krueger64 enrolled11 locationsNCT05104983
Recruiting
Phase 1Phase 2
A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)
Epilepsy, Temporal Lobe
Neurona Therapeutics10 enrolled17 locationsNCT06422923
Recruiting
STXBP1 and SYNGAP1 Related Disorders Natural History Study
Genetic DiseaseSYNGAP1-Related Intellectual DisabilitySTXBP1 Encephalopathy With Epilepsy
Children's Hospital of Philadelphia600 enrolled5 locationsNCT06555965